adenosine monophosphate has been researched along with Critical Illness in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 15 (100.00) | 2.80 |
Authors | Studies |
---|---|
Antonelli, M; Bello, G; Carelli, S; Cesarano, M; Cutuli, SL; De Pascale, G; Di Muro, M; Grieco, DL; Montini, L; Pintaudi, G; Rosà, T; Tanzarella, ES; Vargas, J; Xhemalaj, R | 1 |
Drosos, AA; Pelechas, E; Voulgari, PV | 1 |
Bosma, LBE; Leegwater, E; Moes, DJAR; Ottens, TH; van der Meer, IM; van Nieuwkoop, C; Wilms, EB | 1 |
Atluri, S; Hirsch, JA; Manchikanti, L | 1 |
Avery, RK; Boyarsky, BJ; Durand, CM; Garonzik-Wang, JM; Getsin, SN; Jackson, KR; Kernodle, AB; Massie, AB; Po-Yu Chiang, T; Segev, DL; Van Pilsum Rasmussen, SE; Werbel, WA | 1 |
Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J | 1 |
Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R | 1 |
Ledford, H | 1 |
Agrati, C; Ascoli Bartoli, T; Avataneo, V; Capobianchi, MR; Caputi, P; Castilletti, C; D'Avolio, A; Forini, O; Ippolito, G; Lalle, E; Marchioni, L; Nicastri, E; Notari, S; Scorzolini, L; Tempestilli, M | 1 |
Abraham, OC; John, R; Karthik, R; Manesh, A; Varghese, GM | 1 |
Andini, R; Bertolino, L; Corcione, A; De Rosa, R; Durante-Mangoni, E; Florio, LL; Galdo, M; Mele, F; Zampino, R | 1 |
Ara, MF; Cabañas, F; Calvo, C; Gonzalez Del Valle, L; Melendo, S; Méndez-Echevarría, A; Morales-Martínez, A; Pérez-Martínez, A; Remesal, A; Ruiz de Valbuena, M; Sándor-Bajusz, KA; Vazquez-Martinez, JL | 1 |
An, MH; Hwang, TH; Kim, MS; Kim, WJ | 1 |
Ahmed, M; Begum, SM; Islam, B; Islam, Z | 1 |
Kumar, R; Mahendra, M; Mahesh, PA; Nuchin, A; Shreedhar, S | 1 |
4 review(s) available for adenosine monophosphate and Critical Illness
Article | Year |
---|---|
Treatment strategies of COVID-19: A rheumatology perspective.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal; COVID-19 Drug Treatment; Critical Illness; Cytokine Release Syndrome; Cytokines; Humans; Rheumatology; SARS-CoV-2 | 2022 |
Clinical management of COVID-19.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Airway Management; Alanine; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Critical Illness; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Shock; Specimen Handling; Symptom Assessment; Vulnerable Populations | 2020 |
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Critical Illness; Hospitalization; Humans; Hydroxychloroquine; Immunization, Passive; Network Meta-Analysis; Observational Studies as Topic; Randomized Controlled Trials as Topic | 2020 |
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; COVID-19; Creatine Kinase; Critical Illness; Dexamethasone; Electromyography; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Muscle, Skeletal; Muscular Diseases; Neural Conduction; Pulmonary Embolism; Quadriplegia; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Staphylococcal Infections; Ventilator Weaning | 2021 |
11 other study(ies) available for adenosine monophosphate and Critical Illness
Article | Year |
---|---|
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.
Topics: Adenosine Monophosphate; Alanine; Cohort Studies; COVID-19 Drug Treatment; Critical Illness; Dexamethasone; Humans; Noninvasive Ventilation; Oxygen; Prospective Studies | 2022 |
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients.
Topics: Adenosine; Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; COVID-19 Drug Treatment; Critical Illness; Furans; Humans; Monte Carlo Method; Triazines | 2022 |
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Topics: Adenosine Monophosphate; Alanine; Analgesia; Antiviral Agents; Betacoronavirus; China; Compassionate Use Trials; Cord Blood Stem Cell Transplantation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Critical Illness; Cytokines; Humans; Hydroxychloroquine; Mesenchymal Stem Cell Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Umbilical Cord; United States; Viral Vaccines | 2020 |
Early impact of COVID-19 on transplant center practices and policies in the United States.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Illness; Evidence-Based Medicine; Health Policy; Humans; Hydroxychloroquine; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Living Donors; Organ Transplantation; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; Surveys and Questionnaires; Tissue Donors; Transplant Recipients; United States | 2020 |
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea Nitrogen; C-Reactive Protein; Child; Child, Preschool; Coronavirus Infections; COVID-19; Creatinine; Critical Illness; Dyspnea; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Natriuretic Peptide, Brain; New York City; Pandemics; Pediatric Obesity; Platelet Count; Pneumonia, Viral; Procalcitonin; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Sepsis; Shock, Septic; Tertiary Care Centers; Young Adult | 2020 |
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes | 2020 |
Coronavirus breakthrough: dexamethasone is first drug shown to save lives.
Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Dexamethasone; Humans; Pandemics; Pneumonia, Viral; Preprints as Topic; Randomized Controlled Trials as Topic; Respiration, Artificial; Risk Assessment; Survival Rate | 2020 |
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Female; Humans; Male; Pandemics; Pneumonia, Viral; Recovery of Function; SARS-CoV-2 | 2020 |
Liver injury in remdesivir-treated COVID-19 patients.
Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Italy; Liver Function Tests; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Compassionate use of remdesivir in children with COVID-19.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; Compassionate Use Trials; COVID-19 Drug Treatment; Critical Illness; Female; Humans; Infant; Male; Severity of Illness Index; Spain; Treatment Outcome | 2021 |
Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; COVID-19; Critical Illness; Female; Hospital Mortality; Hospitalization; Humans; India; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2021 |